Bioqual Inc logo

BIOQ - Bioqual Inc Share Price

$85 0.0  0.0%

Last Trade - 5:22pm

Small Cap
Market Cap £54.9m
Enterprise Value £49.5m
Revenue £38.7m
Position in Universe 5216th / 6651
Unlock BIOQ Revenue
Relative Strength (%)
1m +1.72%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -7.61%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st May 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
28.9 33.1 36.6 35.9 39.5 46.4 +9.9%
+566.6 +49.9 +38.7 -9.8 -23.0 +53.7
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 November 2020, BIOQUAL,Inc. revenues increased 34% to $28.5M. Net income increased46% to $3.2M. Revenues reflect Commercial andOther-Fixed-Price-Per-Unit and Time-And-Mater segmentincrease of 71% to $16.4M, Commercial andOther-Fixed-Fixed-Price-Milestone segment increase of 42%to $6.8M. Net income benefited from Interest Expensedecrease from $10K (expense) to $0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for BIOQ
Graphical History


BIOQ Revenue Unlock BIOQ Revenue

Net Income

BIOQ Net Income Unlock BIOQ Revenue

Normalised EPS

BIOQ Normalised EPS Unlock BIOQ Revenue

PE Ratio Range

BIOQ PE Ratio Range Unlock BIOQ Revenue

Dividend Yield Range

BIOQ Dividend Yield Range Unlock BIOQ Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BIOQ EPS Forecasts Unlock BIOQ Revenue
Profile Summary

Bioqual, Inc. is a provider of research, development, consulting and testing/assay services to commercial clients and Government laboratories. The Company supports the National Institutes of Health by providing research services in the research areas of cancer, acquired immune deficiency syndrome (AIDS), hepatitis, influenza, immunology, transgenics, contraception, breeding and development of genetically defined animals, and neurobiology and behavior. The Company's research contracts consist of cancer virus studies, congenic animal development and monoclonal antibody research. The Company's research services include primate biology and medicine, small laboratory animal sciences, infectious disease research, in vitro laboratory services, environmental enrichment and behavior, good laboratory practice (GLP) studies, and partnerships for contracts and grants. The Company holds government contracts, which utilize the non-human primate model to study assorted human diseases.

Last Annual May 31st, 2020
Last Interim November 30th, 2020
Incorporated January 5, 1982
Public Since July 14, 1983
No. of Shareholders: n/a
No. of Employees: 108
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange Pink Sheets on Nasdaq
Shares in Issue 894,416
Free Float (0.0%)
Eligible for
BIOQ Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for BIOQ
Upcoming Events for BIOQ
Frequently Asked Questions for Bioqual Inc
What is the Bioqual Inc share price?

As of 5:22pm, shares in Bioqual Inc are trading at $85, giving the company a market capitalisation of £54.9m. This share price information is delayed by 15 minutes.

How has the Bioqual Inc share price performed this year?

Shares in Bioqual Inc are currently trading at $85 and the price has moved by 54.55% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bioqual Inc price has moved by 20.61% over the past year.

What are the analyst and broker recommendations for Bioqual Inc?

There are no analysts currently covering Bioqual Inc.

When will Bioqual Inc next release its financial results?

Bioqual Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-11-30
What is the Bioqual Inc dividend yield?

The Bioqual Inc dividend yield is 0.82% based on the trailing twelve month period.

Does Bioqual Inc pay a dividend?

Last year, Bioqual Inc paid a total dividend of 0.7, and it currently has a trailing dividend yield of 0.82%. Looking ahead, Bioqual Inc has not announced an ex-dividend date yet.

When does Bioqual Inc next pay dividends?

Bioqual Inc has yet to annouce their ex-dividend date. The historic dividend yield on Bioqual Inc shares is currently 0.82%.

How do I buy Bioqual Inc shares?

To buy shares in Bioqual Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Bioqual Inc?

Shares in Bioqual Inc are currently trading at $85, giving the company a market capitalisation of £54.9m.

Where are Bioqual Inc shares listed? Where are Bioqual Inc shares listed?

Here are the trading details for Bioqual Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: BIOQ
What kind of share is Bioqual Inc?

Based on an overall assessment of its quality, value and momentum, Bioqual Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Bioqual Inc share price forecast 2021?

We were not able to load any forecast data for Bioqual Inc.

How can I tell whether the Bioqual Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioqual Inc. Over the past six months, the relative strength of its shares against the market has been 12.96%. At the current price of $85, shares in Bioqual Inc are trading at 57.21% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Bioqual Inc PE Ratio?

The Bioqual Inc PE ratio based on its reported earnings over the past 12 months is 14.5. The shares are currently trading at $85.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Bioqual Inc?

Bioqual Inc's management team is headed by:

David Newcomer - CFO
Chander Sarma - VPR
Mark Lewis - CHM
Nancy Madden - VAD
Hanne Andersen - DRC
David Landon - DRC
Who are the major shareholders of Bioqual Inc?

Here are the top five shareholders of Bioqual Inc based on the size of their shareholding:

Similar to BIOQ
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.